Omega Therapeutics stock hits 52-week low at $0.89 By Investing.com
In a difficult 12 months for Omega Therapeutics, the biotechnology agency’s inventory has reached a brand new 52-week low, buying and selling at $0.89. This newest value level underscores a interval of serious decline for the corporate, with its inventory worth having plummeted by 49.45% over the previous 12 months. Buyers have been carefully monitoring … Read more